entertainment -WSS

entertainment

author：leisure time 2025-09-30 01:13:15 - browse：28

Apellis Pharmaceuticals said Tuesday that it had identified “internal structural variations” in a type of needle used by doctors to prepare syringes of its eye disease drug Syfovre as a possible cause of severe eye inflammation reported in patients receiving the treatment — but the company stopped short of definitively linking the needle to the cases.

Additionally, Apellis confirmed one additional case of the severe and potentially blinding side effect, known as retinal occlusive vasculitis, or ROV, that occurred in May. But with thousands of more Syfovre eye injections also performed, the overall frequency of ROV remains unchanged and rare, even with the added scrutiny and increased physician monitoring.

Apellis shares rose 30% to $40 in Wednesday’s pre-market trading on the growing belief amongst investors that Syfovre’s safety crisis is abating.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Activists slam private health insurers over coverage restrictions
Next article： GOP inquiry over gain

Wikipedia

WSS

What to make of Biden’s latest efforts on cancer research

WATCH: Why do bright lights make us see spots?

Listen: Covid's latest surge, Alnylam at the FDA, & the end of an era

Ukrainian soldiers say they owe lives to US

WATCH: Why do bright lights make us see spots?

Wildfire smoke map: Which US cities are forecast to be impacted by fires burning in Canada

focus

entertainment

focus

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Regeneron agrees to White House price limits on anti

ChatGPT in medicine: STAT answers readers' burning questions

Illumina to lay off 10% of research and development team

BioMarin wins approval for gene therapy to treat hemophilia A

GOP hopefuls to address prominent, controversial group questioning what's taught in schools

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Regeneron agrees to White House price limits on anti

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Generate Biomedicines machine learning biotech raises $273M

explore

New lesbian bars spark hope amid disappearing LGBTQ+ spaces

Illumina to lay off 10% of research and development team

GOP inquiry over gain

Long Covid needs a new name — and a new frame

Food makers tried to stack nutrition panel with preferred experts

Tuskegee Airman Raymond Cassagnol dies at 102

explore

Wikipedia

Wikipedia

hotspot